Mesalazine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00244 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 29 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | congenital hypotrichosis with juvenile macular dystrophy | KG + DL |
| 2 | osteoarthritis | KG + DL |
| 3 | rheumatoid arthritis | KG + DL |
| 4 | seborrheic keratosis | KG + DL |
| 5 | osteoarthritis susceptibility | KG + DL |
| 6 | vulvar inverted follicular keratosis | KG + DL |
| 7 | pseudoachondroplasia | KG + DL |
| 8 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 9 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 10 | brachydactyly-syndactyly syndrome | KG + DL |
| 11 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 12 | brachyolmia | KG + DL |
| 13 | myosclerosis | KG + DL |
| 14 | arthropathy | KG + DL |
| 15 | granulomatous disease with defect in neutrophil chemotaxis | KG + DL |
| 16 | granulomatous disease, chronic, autosomal recessive, 5 | KG + DL |
| 17 | anus disease | KG + DL |
| 18 | Crohn disease of the esophagus | KG + DL |
| 19 | functional neutrophil defect | KG + DL |
| 20 | gout | KG + DL |
| 21 | cap polyposis | KG + DL |
| 22 | WHIM syndrome | KG + DL |
| 23 | cutaneous photosensitivity-lethal colitis syndrome | KG + DL |
| 24 | seborrheic dermatitis | KG + DL |
| 25 | undetermined colitis | KG + DL |
| 26 | combined immunodeficiency due to moesin deficiency | KG + DL |
| 27 | cholesteatoma (disease) | KG + DL |
| 28 | exostosis | KG + DL |
| 29 | acquired keratosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.